Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$12,914,263
+$3,011,100 QoQ
Shares Held
10,767
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.78%
of 13F equity value
Holder Rank
#1,127
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. LLY ranks #1 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
|
2,375 | $372,210 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,914,263 | 10,767 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $9,903,163 | 10,767 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $11,904,231 | 11,077 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $8,474,641 | 11,107 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $8,673,830 | 11,127 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $9,512,005 | 11,517 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,898,844 | 11,527 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $10,212,230 | 11,527 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $11,433,138 | 12,628 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $10,917,112 | 14,033 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $10,764,783 | 18,467 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $11,914,617 | 22,182 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $10,742,455 | 22,906 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $8,265,432 | 24,068 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $9,169,047 | 25,063 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $8,236,371 | 25,472 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $8,542,812 | 26,348 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $7,588,232 | 26,498 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $7,616,214 | 27,573 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $6,501,515 | 28,139 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $6,504,367 | 28,339 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $5,357,810 | 28,679 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,016,067 | 29,709 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $4,569,969 | 30,874 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $5,118,147 | 31,174 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,081,591 | 36,632 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||